Purpose: To prospectively evaluate the accuracy of automated hippocampal volumetry to distinguish between patients with Alzheimer's disease (AD), patients with mild cognitive impairment (MCI) and elderly controls, using established criteria for patients with AD and MCI as the reference standard.
Introduction
Alzheimer's disease (AD) is the most common cause of dementia in the elderly (1) .
Early and accurate diagnosis of AD can be challenging. In recent years, the early clinical signs of AD have been extensively investigated, leading to the concept of amnestic Mild Cognitive Impairment (MCI) (2) (3) (4) . A challenge for modern neuroimaging is to help in the diagnosis of early AD and particularly in amnestic MCI patients. Early diagnosis of AD patients allows early treatment with cholinesterase inhibitors, which have been shown to delay institutionalization, improve or stabilize cognition and behavioral symptoms (5, 6) .
Three-dimensional (3D) magnetic resonance imaging (MRI) with high spatial resolution allows visualization of subtle anatomical changes and thus can help in the detection of brain atrophy at the beginning of the disease. The hippocampus is known to be affected in the earliest stages of AD (7, 8) . Many studies have thus assessed hippocampal atrophy in AD using manual segmentation on MRI (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . These studies have demonstrated that manual MR volumetry of the hippocampus can distinguish patients with AD from elderly controls with a high degree of accuracy (80% to 90%).
However, manual segmentation of the hippocampus requires a high degree of anatomical training, is observer-dependent and time consuming (up to more than one hour). Although more suitable in clinical practice, visual evaluation of atrophy on multiplanar MRI is difficult and prone to subjectivity (20) .
We have developed an automated method that is able to segment the hippocampus on MRI (21) . This method has been compared to manual segmentation in young healthy participants and patients with AD and has proved to be reliable, fast and accurate (about 8% relative volume error when compared to manual segmentation) (21) .
Thus, the purpose of our study was to prospectively evaluate the accuracy of automated
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Materials and Methods

Participants
The regional ethics committee approved the study and written informed consent was obtained from all participants. All patients were capable of giving informed consent.
Written informed consent was given by the patients themselves. In our study, 25 patients with AD (11 males, 14 females, age ± standard-deviation (SD) = 73 ± 6 years, range = 62-81 years, mini-mental score (MMS) = 24.4 ± 2.7, range = 19-29) and 24 patients with amnestic MCI (10 males, 14 females, age ± SD = 74 ± 8 years, range = 55-87 years, MMS = 27.2 ± 1.4, range = 24-29) were selected from the database of patients prospectively recruited at the Centre Hospitalo-Universitaire (CHU) of Caen.
From this database, we included participants whose scanning parameters followed the protocol described below and whose MRI was free of substantial visible motion artifacts. These samples partly overlap with those of previous publications (22) (23) (24) (25) . The diagnosis for probable AD was made according to the NINCDS-ADRDA (National Institute of Neurological and Communicative Diseases and Stroke-Alzheimer's Disease and Related Disorders Association) criteria (26) . The diagnosis of MCI was based on Petersen et al.'s criteria (27) . All MCI patients were evaluated every 6 months over an 18-month period to assess conversion, i.e., whether they met NINCDS-ADRDA criteria of probable AD or not. Patients were declared as converters if they had impaired performances (more than 1.5 SD below the normal means according to age and education when available) in at least one of general intellectual function scales as well as in at least two areas of cognition including memory, leading to impaired daily activities as judged by the clinicians from the consultation interviews. Post hoc exclusion criteria included presence of substantial neurological, psychiatric or any other medical disease that could affect brain functioning or structure, and normal episodic Control participants were recruited through advertisement in local newspapers. Control participants were required to be over 50 years old. There was no specific sex criterion.
The recruitment of participants (controls and patients) began in 1999 and ended in 2004.
MRI acquisition
Within an interval of two months at most from inclusion for the controls and a few days for MCI and AD patients, each participant underwent a T1-weighted volume MRI scan, which consisted of a set of 128 adjacent axial cuts parallel to the anterior commissure -posterior commissure (AC-PC) line and with slice thickness 1.5 mm and 
Automated segmentation of the hippocampus
The segmentation of the hippocampus was performed using an automated method we previously developed. This approach segments both the hippocampus and the amygdala simultaneously based on competitive region-growing between these two structures. It includes prior knowledge on the relative positions of these structures with respect to anatomical landmarks which are automatically identified. During the iterative segmentation process, eleven sets of landmarks were automatically retrieved at the border of the deforming structures. Two of these landmarks were located at the interface between the hippocampus and the amygdala, based on the alveus and the temporal horn of the lateral ventricle. Three of them were defined for the hippocampus only: two based on the alveus and one on the hippocampal sulcus. One was defined for the amygdala only, based on the isthmus of the temporal lobe. Finally, five were defined for both the hippocampus and the amygdala, based on the parahippocampal gyrus and the temporal horn of the lateral ventricle. More details can be found in a previously published paper (21) . It should be noted that all these landmarks were found automatically by the algorithm and that no intervention from the operator was required.
It is thus not necessary to be able to locate these landmarks on the MRI to use the automated segmentation software.
Segmentations (Figures 1 and 2 ) were processed by a trained operator (O.C.) who was blind to all clinical data and diagnostic categories. The operator had six years of other geometric parameter controls the anisotropy in the tail of the hippocampus. These two geometric parameters are adjusted when the hippocampus is atrophied. The average total processing time for each amygdalo-hippocampal complex (measured on a subset of ten participants: three controls, two MCI and five AD patients ) was 11 minutes for the complete procedure, including bounding box definition, seeds positioning, parameter adjustment and automatic deformation by the algorithm. Intrarater reproducibility was assessed by performing the segmentation twice, after a one week interval, on a randomly selected subsample of 10 participants (three AD, three MCI and four controls). The rater was blind to all previous parameters or visualization adjustments.
The mean intra-rater relative volume difference was 7% ± 7 (mean ± SD). The difference between the two measurements was not statistically significant (p=0.4, paired
Student's t-test).
Normalization with Total Intracranial Volume (TIV)
For subsequent classification of AD patients and healthy controls, hippocampal measurements were normalized to the total intracranial volume (TIV). The TIV was computed using SPM5 (Statistical Parametric Mapping) software (Wellcome Department of Imaging Neuroscience, London, UK) according to the following procedure:
-correction for intensity non-uniformity, spatial normalization to a common stereotaxic space and tissue classification into gray matter (GM), white matter (WM) and cerebro-spinal fluid (CSF) using a unified procedure (29);
-creation of an approximate intra-cranial mask by summing the three unmodulated tissue probability maps and thresholding the result at 0.5 (this removes some non-CSF voxels that were included in the CSF map by the 
Statistical analysis
The statistical analysis was conducted by O.C. using in-house software developed by B.M. and H.B.
Group analysis. Group differences in normalized hippocampal volume between AD patients, MCI patients, and healthy controls were assessed using Student's T-tests. To obtain a more robust estimate of the p-value, we used a bootstrap method (31) . In brief, this method proceeds as follows. Let us denote S 1 the group of controls and S 2 the group of patients and S the union of these groups. We worked with the null hypothesis that there are no differences between the mean values of the two groups. We resampled the set S under the null hypothesis, creating resampled sets S 1 * and S 2 * by drawing with replacement participants from both groups. For the n-th resampling S 1 *,n , S 2 *,n we computed the corresponding value T *,n of the T-test. We performed 5000 resampling . The remaining 25% were used as a test set. The procedure was repeated 5000 times. We thus obtained the correct classification rates, the sensitivity and the specificity for the 5000 drawings.
The classification was also analyzed using ROC (receiver operating characteristic) curves. The ROC curve indicates the relationship between sensitivity and 1-specificity for each inter-group discrimination. We computed the area under the curve (AUC) which is an index of overall discriminative ability.
Subgroup analysis.
To ensure that our findings were not biased by age or sex confounding effects, the same group and individual analyses were also performed on smaller groups of age-matched participants. To this purpose, we selected a group of 17 AD patients (6 males, 11 females, age ± standard-deviation (SD) = 70 ± 4 years, range = 62-76 years, mini-mental score (MMS) = 24.1 ± 2.8, range = 19-28), a group of 17 MCI patients (6 males, 11 females, age ± standard-deviation (SD) = 70 ± 6 years, range = 55- (Figure 3) . The converter subgroup was too small to compute a p-value.
Individual analysis
Correct classification rates were 84% for AD patients and 73% for MCI patients with respect to elderly controls, and 69% for AD patients with respect to MCI patients (Table 2 ).
Regarding the ROC curves for inter-group discrimination (Figure 4) 
Discussion
Our study showed that automated segmentation was able to detect significant volume differences in both AD patients and patients with amnestic MCI. The results are in concordance with a vast number of studies based on manual hippocampal segmentation which have shown hippocampal atrophy in patients with Alzheimer's disease (e.g, (10-15, 18, 19) and in patients with MCI (32-37). Compared to elderly controls, we found an average 32% hippocampal volume loss in patients with AD. This value is in the range of those reported in studies that used manual volumetry, with volume loss in AD comprised between 23% and 34% (10, 12, 17, 18, 33) . In patients with MCI, values ranged from 8% to 15% (32) (33) (34) (35) 37) . We found a slightly higher relative volume loss in these patients (19%). However, it is important to note that MCI criteria are highly variable from one study (or laboratory) to another, as are the annual rates of conversion to AD. As a result, the degree of hippocampal atrophy, which appropriately depends on the underlying aetiology, the severity of symptoms, and the proportion of converters, similarly shows inconsistencies. In our opinion, the slightly higher degree of atrophy found in our study should be related to the relatively high conversion rate of our MCI sample (23% each year), which is higher than that usually reported (about 15%). This rate should in turn reflect the use of strict criteria, including objective memory deficits, normal global cognition (as attested using objective tests), and excluding impairment in other areas of cognition (also objectively assessed) or depression.
Using normalized hippocampal volumes, 84% of AD patients were correctly classified with respect to elderly controls. This value falls within the range of classification results based on manual segmentation of the hippocampus, which was comprised between 82% and 90% for AD (10, 12, 17, 18, 33) . For MCI patients, classification rates ranged from 60% to 74% (32) (33) (34) (35) 37) . We found a discrimination rate of 73%. As for the degree of atrophy, this relatively high value should be related to the high conversion rate and thus to the use of strict criteria.
We found that MCI patients who later converted to AD had a 20% smaller hipppocampal volume at baseline than non-converters. This result should be interpreted with caution due to the small number of converters. Nevertheless, this is in agreement with several studies based on manual segmentation which have reported that baseline hippocampal volume is an indicator of future progression to AD (38) (39) (40) (41) (42) . This is also in concordance with studies based on visual rating which demonstrated medial temporal atrophy in patients who subsequently converted to AD (43) (44) (45) the high-dimensional brain mapping (HDBM) approach, based on fluid registration with a template, to obtain hippocampal volumes and hippocampal shape differences between patients with very mild AD and controls (54) . Using a classification based on both volume and shape features, they achieved a sensitivity of 83% and a specificity of 78%.
However, they did not assess the classification performance based on volume alone.
Using a similar HDBM approach, Hsu et al. compared automated and manual segmentations in AD and cognitively impaired patients (55) . They reported good correlations between manual and automated measurements. However, they did not investigate the accuracy of this technique for the classification of individual patients.
The results of our study require confirmation in larger groups of participants.
However, the use of bootstrap resampling techniques allows computing robust estimates for relatively small groups of patients. In order to keep the control group as large as possible, we decided not to exclude control participants based on age or gender. As a consequence, the mean age of the healthy controls was lower than those of the AD and MCI patients. However, to ensure that our findings were not biased by age or sex confounding effects, we also performed the same analysis on smaller groups of agematched and sex-matched participants and obtained similar results. Nevertheless, future studies on larger age-and sex-matched groups of participants are required to confirm our results. Finally, in our study, the automated segmentations were performed by only one rater, excluding the ability to evaluate inter-operator repeatability. In a previous
paper (21) we have assessed the inter-rater reproducibility of the automated segmentation in healthy controls and patients with AD and reported a high reproducibility (the average volume difference between operators was 4% for healthy controls and 7% for AD patients).
Using automated segmentation of the hippocampus, we were able to individually classify Alzheimer's disease, mild cognitive impairment and control participants with a high degree of accuracy. This method can serve as an alternative to manual tracing and may become a useful tool to assist in the diagnosis of Alzheimer's disease. 
Colliot et al., Automated hippocampal volumetry in Alzheimer's disease
